Clorox expects fiscal 2027 adjusted EPS near low end of guidance as costs rise
CLX•Clorox expects fiscal 2027 adjusted EPS near the low end of its unchanged $5.70-$6.00 range, with input cost headwinds estimated at about $240 million. Sales growth guidance remains unchanged at 13%-14%.
1. Outlook and costs
Clorox expects fiscal 2027 adjusted EPS near the low end of its unchanged $5.70-$6.00 guidance range. It estimates input cost headwinds of approximately $240 million, driven primarily by higher commodity and transportation costs.
2. Sales and margins
Net sales growth guidance remains 13%-14%, including about 9.5 percentage points from the GOJO acquisition. Organic sales growth remains projected at 3.5%-4.5%, including more than 3.5 percentage points from lapping ERP-related inventory drawdowns. Clorox forecasts gross margin of about 41.5% and selling and administrative expenses of about 15.5% of net sales.
